 This is a sensible safe approach to the phased development of a novel nerve reconstruction device. It stands in contrast to other products that have been introduced without due testing. Functional outcome measurement is challenging, the existing tests being insufficiently specific for fine discriminatory purposes, but the authors suggest a sensible pragmatic approach for this phase of study. Safety is well addressed. Ethics are well addressed. Data governance is addressed. 